We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Advanced Temperature Controller for Microfluidic Devices for Biotech Research Introduced

By LabMedica International staff writers
Posted on 30 Sep 2014
An innovative temperature controller for use in microfluidic applications is available for use by biotech and other life science researchers.

The microfluidics specialty company Dolomite (Royston, United Kingdom) introduced its new Meros TCU-100 temperature controller at the September 18–19, 2014, Lab-on-a-Chip & Microarray World Congress held in San Diego (CA, USA).

The Meros TCU-100 is the first module in the company's new Meros range of plug-and-play microfluidic products. More...
This line consists of a suite of integrated tools, specifically targeted at microfluidics users in research and education, with the ambition of providing a sophisticated suite of intelligently coordinated capabilities. The suite is be based around a modern touch-screen interface enabling clear visualization of data and virtual reconfiguration of the connected hardware such as pumps and valves. The intuitive and easy to use connections to microfluidic devices is be based on Dolomite’s existing range of microfluidic connectors, Multiflux.

The new Meros TCU-100 temperature controller, which offers advanced temperature control from 1–100 °C, was designed to accommodate a wide range of biological and chemical applications, including cell analysis, thermal control of microreactors, incubation of microdroplets, protein crystallization, nanoparticle synthesis, and thermocycling of micro-scale samples. The instrument is accurate within 0.5 °C with stability and target temperature resolution of 0.1 °C and rapid ramp rates up to 1 °C per second. Operation, data logging, and graphical data display are achieved through Dolomite’s user-friendly Flow Control Center software or third-party software.

“At Dolomite, we believe the scientist should be free to focus on science and not have to worry about finding the right tools for their job. That is why we will provide researchers with a next generation of plug and play microfluidic platforms for use in the laboratory,” said Andrew Lovatt, CEO of Dolomite. “Once again, Dolomite will apply its world-leading expertise in microfluidic solutions to development of innovative technologies.”

Related Links:

Dolomite



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hematology Consumables
Bioblood Devices
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: (a) CTC separation using contraction-expansion inertial microfluidics. (b) CTC detection using the YOLOv8 deep learning model. (Image Credit: Junyi Ouyang, Haiqin Li)

Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis

Liquid biopsy relies on detecting rare tumor-derived material in blood, but circulating tumor cells (CTCs) are especially difficult to capture because they are vastly outnumbered by normal blood cells.... Read more

Molecular Diagnostics

view channel
Image: Congenital cytomegalovirus can go unnoticed at birth despite later risks to hearing and development (Image Credit: 123RF)

Pooled Saliva PCR Screening Identifies Congenital CMV Missed by Targeted Testing

Congenital cytomegalovirus (cCMV) can be present in newborns who appear healthy and pass routine hearing screening. The infection is one of the most common maternal-to-fetal infections during pregnancy... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.